KALA BIO, Inc. — Form D

KALA BIO, Inc. of ARLINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-31. The offering totals $10.7M, of which $10.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (44)

Showing 25 of 44 people.

NameRoleLocation
Marjan D FaridDirectorArlington, MA
Mark IwickiDirectorArlington, MA
Andrew I KovenDirectorBoston, MA
C. Daniel MyersDirectorArlington, MA
Gregory D PerryDirectorArlington, MA
Howard B RosenDirectorSan Mateo, CA
Todd BazemoreExecutive OfficerFRAMINGHAM, MA
Kim BrazzellExecutive OfficerArlington, MA
Mark IwickiExecutive OfficerArlington, MA
Darius KharabiExecutive OfficerArlington, MA
Mary ReumuthExecutive OfficerArlington, MA
Robert LangerDirectorPittsburgh, PA
Kevin BittermanDirectorCambridge, MA
Andrew L KovenDirectorCambridge, MA
David LazarDirectorARLINGTON, MA
Brendan PurdyDirectorArlington, MA
Mark S BlumenkranzDirectorArlington, MA
PETER COUROSSIExecutive OfficerChicago, IL
Robert TepperDirectorCambridge, MA
Greg GrunbergDirectorLawrence, MA
Darius Daniel KharabiExecutive OfficerWatertown, MA
Gregory D GrunbergDirectorWatertown, MA
Hongming ChenExecutive OfficerWatertown, MA
Robert D PaullDirectorWatertown, MA
Eric L TrachtenbergExecutive OfficerWatertown, MA

Other filings by this issuer (11)

FiledFormOfferingSold
2026-03-17D$1.8M$1.8M
2026-02-13D$4.2M$2.3M
2024-06-28D$12.5M$12.5M
2021-11-29D$36.5M$16.1M
2016-04-13D$67.9M$67.9M
2015-08-19D$7.0M$7.0M
2014-04-24D$22.5M$22.5M
2013-02-28D$11.5M$5.8M
2012-03-14D$7.2M$7.2M
2010-11-10D$3.0M$3.0M
2009-12-23D$2.0M$2.0M

More